Position in ERAS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,486,008
+$1,742,797 QoQ
Shares Held
153,647
-23.1% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Derivatives in ERAS
reported options exposure · as of Mar 31, 2026CallValue
$18,793,070
CallShares
1,161,500
PutValue
$2,643,812
PutShares
163,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,173,997,525 across 354 Biotechnology names. ERAS ranks #96 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
898,951 | $59,249,860 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,268 | $57,660,053 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,344,953 | $45,499,759 | |
| 4 | ABVX |
Abivax S.A.
|
381,282 | $42,455,750 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
398,943 | $29,625,507 | |
| 6 | INSM |
INSMED Inc
|
173,630 | $28,391,977 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
593,406 | $28,228,323 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
521,571 | $27,497,223 |
All Filings in ERAS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,643,812 | 163,400 | Put | Other | 2026-05-15 | |
| 2026-03-31 | $2,486,008 | 153,647 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $18,793,070 | 1,161,500 | Call | Other | 2026-05-15 | |
| 2025-12-31 | $1,635,312 | 439,600 | Call | Other | 2026-02-17 | |
| 2025-12-31 | $743,211 | 199,788 | Shares | Other | 2026-02-17 | |
| 2025-12-31 | $46,500 | 12,500 | Put | Other | 2026-02-17 | |
| 2025-09-30 | $40,548 | 18,600 | Call | Other | 2025-11-14 | |
| 2025-09-30 | $233,787 | 107,242 | Shares | Other | 2025-11-14 | |
| 2025-09-30 | $35,534 | 16,300 | Put | Other | 2025-11-14 | |
| 2025-06-30 | $391,968 | 308,637 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $324,621 | 236,950 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $80,069 | 31,900 | Put | Other | 2025-02-14 | |
| 2024-12-31 | $289,907 | 115,501 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $162,432 | 59,499 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $188,643 | 69,100 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $50,778 | 18,600 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $116,912 | 49,539 | Shares | Defined | 2024-08-15 | |
| 2024-06-30 | $132,396 | 56,100 | Put | Defined | 2024-08-15 | |
| 2024-03-31 | $22,042 | 10,700 | Put | Defined | 2024-05-07 | |
| 2024-03-31 | $124,642 | 60,506 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $131,536 | 61,754 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $261,948 | 132,969 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $460,902 | 166,994 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $40,635 | 13,500 | Put | Defined | 2023-05-16 | |
| 2023-03-31 | $1,093,743 | 363,370 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $88,786 | 20,600 | Call | Defined | 2023-02-14 | |
| 2022-12-31 | $109,805 | 25,477 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $331,250 | 42,468 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $262,179 | 30,486 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||